1. Home
  2. PAR vs SLNO Comparison

PAR vs SLNO Comparison

Compare PAR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$34.33

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$51.36

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
SLNO
Founded
1968
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
2.5B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PAR
SLNO
Price
$34.33
$51.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$64.00
$110.90
AVG Volume (30 Days)
737.4K
1.8M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$440,451,000.00
$98,675,000.00
Revenue This Year
$30.40
N/A
Revenue Next Year
$12.01
$155.86
P/E Ratio
N/A
N/A
Revenue Growth
39.88
N/A
52 Week Low
$31.65
$41.50
52 Week High
$81.51
$90.32

Technical Indicators

Market Signals
Indicator
PAR
SLNO
Relative Strength Index (RSI) 44.28 48.33
Support Level $33.74 $47.80
Resistance Level $35.62 $53.10
Average True Range (ATR) 1.65 2.47
MACD 0.07 1.09
Stochastic Oscillator 37.11 79.48

Price Performance

Historical Comparison
PAR
SLNO

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: